KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Equity Income (2016 - 2025)

Quest Diagnostics' Equity Income history spans 17 years, with the latest figure at $7.0 million for Q4 2025.

  • For Q4 2025, Equity Income rose 40.0% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $42.0 million, up 121.05%, while the annual FY2025 figure was $42.0 million, 121.05% up from the prior year.
  • Equity Income for Q4 2025 was $7.0 million at Quest Diagnostics, down from $8.0 million in the prior quarter.
  • Across five years, Equity Income topped out at $31.0 million in Q1 2022 and bottomed at $3.0 million in Q4 2022.
  • The 5-year median for Equity Income is $8.0 million (2023), against an average of $11.0 million.
  • The largest annual shift saw Equity Income tumbled 88.0% in 2022 before it soared 166.67% in 2023.
  • A 5-year view of Equity Income shows it stood at $25.0 million in 2021, then crashed by 88.0% to $3.0 million in 2022, then skyrocketed by 166.67% to $8.0 million in 2023, then plummeted by 37.5% to $5.0 million in 2024, then soared by 40.0% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Equity Income are $7.0 million (Q4 2025), $8.0 million (Q3 2025), and $9.0 million (Q2 2025).